News | March 01, 2025
Healthcare Triangle announces $15.2 million PIPE offering
The PIPE offering consists of 36,190,476 units
The PIPE offering consists of 36,190,476 units
Yearbook members are selected basis their S&P Global 2024 Corporate Sustainability Assessment score
Amgen India investment totals $200 million through 2025
Findings to form the basis for a Phase 3 program, anticipated to start in H2 2025
Aster commits to increase bed capacity in the State via capacity expansion and greenfield projects
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
This Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability
The company will offer end-to-end services and solutions for the sector with a specific focus on sustainability
These results represent critical milestones for Philogen, as Fibromun has the potential to become second product to successfully complete multinational clinical trials with registration potential
The company will initially supply prototypes to diverse customers to evaluate in purification processes for producing gene therapy drugs with a view to swift commercialization
Subscribe To Our Newsletter & Stay Updated
